心血管病防治知识（下半月）
心血管病防治知識（下半月）
심혈관병방치지식（하반월）
XINXUEGUANBING FANGZHI ZHISHI
2013年
11期
4-5
,共2页
厄贝沙坦氢氯噻嗪复方片%轻中度高血压
阨貝沙坦氫氯噻嗪複方片%輕中度高血壓
액패사탄경록새진복방편%경중도고혈압
Irbesartan/hydrochlorothiazide compound tablet%mild to moderate hypertension
目的探讨厄贝沙坦氢氯噻嗪复方片治疗轻中度高血压的临床疗效。方法分析2008年1月至2013年1月我院收治的180例轻中度高血压患者的临床资料，将患者分为2组，比较2组患者的疗效差异。结果对照组患者经厄贝沙坦治疗，降压总有效率为68.89%，治疗组患者经厄贝沙坦氢氯噻嗪片治疗，降压总有效率为87.78%，明显高于对照组，经比较，P<0.05，差异具有统计学意义。结论厄贝沙坦氢氯噻嗪复方片治疗轻中度高血压疗效确切，值得推广使用。
目的探討阨貝沙坦氫氯噻嗪複方片治療輕中度高血壓的臨床療效。方法分析2008年1月至2013年1月我院收治的180例輕中度高血壓患者的臨床資料，將患者分為2組，比較2組患者的療效差異。結果對照組患者經阨貝沙坦治療，降壓總有效率為68.89%，治療組患者經阨貝沙坦氫氯噻嗪片治療，降壓總有效率為87.78%，明顯高于對照組，經比較，P<0.05，差異具有統計學意義。結論阨貝沙坦氫氯噻嗪複方片治療輕中度高血壓療效確切，值得推廣使用。
목적탐토액패사탄경록새진복방편치료경중도고혈압적림상료효。방법분석2008년1월지2013년1월아원수치적180례경중도고혈압환자적림상자료，장환자분위2조，비교2조환자적료효차이。결과대조조환자경액패사탄치료，강압총유효솔위68.89%，치료조환자경액패사탄경록새진편치료，강압총유효솔위87.78%，명현고우대조조，경비교，P<0.05，차이구유통계학의의。결론액패사탄경록새진복방편치료경중도고혈압료효학절，치득추엄사용。
Objective To investigate the clinical efficacy of irbesartan/hydrochlorothiazide compound tablets in the treatment of mild to moderate hypertension. Methods The clinical data of 180 patients with mild to moderate hypertension, who were admitted to our hospital from January 2008 to January 2013, were analyzed. The patients were divided into control group and treatment group to receive irbesartan and irbesartan/hydrochlorothiazide compound tablets, respectively. The treatment outcomes of the two groups were compared. Results The treatment group had a significantly higher response rate than the control group (87.78% vs 68.89%, P<0.05) in antihypertensive treatment.ConclusionIrbesartan/hydrochlorothiazide compound tablets are effective in treating mild to moderate hypertension and hold promise for clinical application.
